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Received 24 June 2010; received in revised form 19 August 2010; accepted 20 August 2010Abstract Unrestricted somatic stem cells (USSC) from human cord blood display a broad differentiation potential for
ectodermal, mesodermal, and endodermal cell types. The molecular basis for these stem cell properties is unclear and unlike
embryonic stem cells (ESC) none of the major stem cell factors OCT4, SOX2, and NANOG exhibits significant expression in
USSC. Here, we report that these key stem cell genes hold an epigenetic state in between that of an ESC and a terminally
differentiated cell type. DNA methylation analysis exhibits partial demethylation of the regulatory region of OCT4 and a
demethylated state of the NANOG and SOX2 promoter/enhancer regions. Further genome-wide DNA methylation profiling
identified a partially demethylated state of the telomerase gene hTERT. Moreover, none of the pluripotency factors
exhibited a repressive histone signature. Notably, SOX2 exhibits a bivalent histone signature consisting of the opposing
histone marks dimeH3K4 and trimeH3K27, which is typically found on genes that are "poised" for transcription. Consequently,
ectopic expression of OCT4 in USSC led to rapid induction of expression of its known target gene SOX2. Our data suggest that
incomplete epigenetic repression and a "poised" epigenetic status of pluripotency genes preserves the USSC potential to be
able to react adequately to distinct differentiation and reprogramming cues.
© 2010 Elsevier B.V. All rights reserved.Introduction
Cellular differentiation and dedifferentiation require global
changes in gene expression regulated in part by epigeneticAbbreviations: USSC, unrestricted somatic stem cells; ESC,
embryonic stem cells; iPS, induced pluripotent stem cells.
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doi:10.1016/j.scr.2010.08.003mechanisms such as DNA methylation and chromatin reorga-
nization. DNA methylation is a covalent modification of
cytosine at position C5 in CpG dinucleotides. By computa-
tional prediction it has been estimated that 29 000 CpG-rich
regions are distributed in the human genome, many of them
spanning the promoter and first exon of approximately 60% of
our genes (Bird, 2002). Typically, if they are methylated the
corresponding gene promoter is constitutively inactivated
(Paz et al., 2003). The methylated state, once established, is
stable for many cell divisions (Bird, 2002)..
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regulation in developmental processes is a dynamic chroma-
tin structure. Active genes are associated with an acetyl
group on lysine 9 of histone 3 (acH3K9), on lysine 8 of histone
H4 (acH4K8), and methyl groups on lysine 4 of histone H3
(meH3K4) (Jenuwein and Allis, 2001; Kouzarides, 2007). On
the other hand, inactive genes bear either a mark for
constitutive heterochromatin such as dimethylation on lysine
9 of histone H3 (dimeH3K9) (Bannister et al., 2001;
Nakayama et al., 2001; Noma et al., 2001) or a mark for
facultative heterochromatin, which is trimethylation on
lysine 27 of histone H3 (trimeH3K27) (Plath et al., 2003).
Genome-wide epigenetic marks must be heritable and
dynamic, in particular during early development where
they ensure differentiation state-specific gene regulation
(Amabile and Meissner, 2009).
The master transcription regulators NANOG, OCT4, and
SOX2 form a basic regulatory network that governs plur-
ipotency and self-renewal in human embryonic stem cells
(ESC) (Boyer et al., 2005). NANOG deficiency in ESC leads to
loss of self-renewal capability (Chambers et al., 2003; Mitsui
et al., 2003) and predisposes the cells to uncommitted
differentiation (Chambers et al., 2007). A critical amount of
OCT4 is required to sustain self-renewal of ESC, whereas up-
or downregulation induces divergent developmental pro-
grams (Niwa et al., 2000). SOX2 maintains pluripotency in
ESC and in neural stem cells (Yuan et al., 1995; Masui et al.,
2007). It is well established that the genes encoding the
three key regulators of stemness all bear differentiation
state-specific epigenetic marks, which undergo changes
during differentiation. Another hallmark of pluripotent
stem cells is telomerase activity. In ESC, active telomerase
is able to maintain telomere length whereas in proliferative
somatic stem cells a tightly regulated telomerase activity
seems not to be sufficient to fully maintain it (Shay and
Wright, 2010).
Pluripotent unrestricted somatic stem cells (USSC) from
human umbilical cord blood reside in an early differenti-
ation state, can be propagated to high cell numbers, and
on treatment with appropriate stimuli display broad
differentiation capabilities in vitro and in vivo (Kögler
et al., 2004, 2006). They thus represent promising
candidates for regenerative and cell replacement thera-
pies. However, an indispensable prerequisite to employ
USSC for such purposes in a controlled manner is a better
understanding of the molecular mechanisms that are
necessary for establishment and maintenance of their
stem cell properties.
Although the epigenetic status of key pluripotency
transcription factors is well characterized in ESC and
terminally differentiated cells, similar analyses are not
available for multipotent somatic stem cells. However,
characterization of the epigenetic modifications that might
be involved in giving somatic stem cells their unique
properties will be of fundamental importance for further
clinical exploitation of USSC and other somatic stem cells.
The major stem cell factors OCT4, NANOG, SOX2, (Kluth
et al., 2010), and hTERT (Aktas et al., 2010) are all not
detectable in USSC at the protein level. Nevertheless, we
hypothesized that the stem cell characteristics of USSC could
be mirrored by a specific epigenetic signature of these major
regulators of pluripotency.Results
Heterogeneous DNA methylation patterns in the
OCT4 5′ and the NANOG promoter region of USSC
It has been shown that repression of OCT4 and NANOG gene
promoters by DNA methylation takes place early in
embryonic development (Gidekel and Bergman, 2002).
Based on previous observations that neonatal USSC have
preserved multipotent differentiation capabilities, we
asked whether the regulatory DNA sequences of these
genes are indeed completely epigenetically repressed in
USSC. Notably, it is well established that culture-linked
alterations in DNA methylation can occur during prolonged
cultivation (Antequera et al., 1990; Meissner et al., 2008).
To avoid cell culture-dependent DNA methylation artifacts
as far as possible, we isolated the cells from freshly
prepared cord blood and expanded them to not more than
four passages to reach sufficient cell numbers for subse-
quent analyses. In Fig. 1A it is shown that the ESC line I3 is
completely free of DNA methylation in the respective OCT4
5′ region as expected. By contrast, in CD34+ hematopoietic
stem and progenitor cells isolated from umbilical cord blood
the same area is completely methylated (Fig. 1A). Notably,
in all USSC cell lines investigated so far we found an
intermediate methylation pattern (Fig. 1B) revealing that
USSC are generally heterogeneous with respect to DNA
methylation of the OCT4 5′ region. Occasionally, OCT4
alleles were found to be completely unmethylated (e.g.,
USSC line 4/146), indicating that at least in a small number
of cells OCT4 exists in an epigenetically activated state. The
DNA methylation differences were also verified by methyl-
ation-specific PCR (supplementary Fig. 1). It is worth noting
that a core region of the examined CpG-rich area, consisting
of the CpG dinucleotides at positions 8 to 12, is more
frequently unmethylated than adjacent CpGs (Fig. 1B),
which might be due to targeting by a yet undefined binding
factor.
Next, the analysis of four CpG dinucleotides residing in
the NANOG promoter was performed for various USSC cell
lines. These CpG sites have been shown previously to be
devoid of methylation in ESC but to become methylated in
the course of gene silencing and differentiation (Hattori
et al., 2007). Patchy DNA methylation of the NANOG
promoter was detected in the USSC line 4/146. The USSC
lines 5/73 and 8/25 show an even lower degree of DNA
methylation with the majority of sequences showing a
completely demethylated status (Fig. 2). Notably, these
findings coincide with the observation that the cell line 4/
146 can be propagated over significantly less population
doublings in an undifferentiated state than the cell lines 5/
73 and 8/25 (data not shown).
The SOX2 promoter/enhancer is unmethylated in
USSC and can be reactivated by ectopic expression
of OCT4
The SOX2 gene promoter and its SRR1 enhancer are
active and unmethylated in ESC and neural stem cells. It
has been shown that these regulatory regions are prone
to epigenetic changes in the course of cellular
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Figure 1 DNA methylation of OCT4 –5′ region in stem cells. Schematic outline of the genomic organization of the OCT4 –5′ region
including relative position of an Alu element, transcription start site (solid arrow), first exon, and CpG dinucleotides (vertical bars)
(A). Dashed arrows demarcate the region analyzed by bisulfite genomic sequencing. The methylation status of this region in the
embryonic stem cell line I3 and CD34+ hematopoietic progenitor cells from cord blood (B). DNA methylation patterns in different USSC
cell lines (C). Blank circles indicate unmethylated CpG dinucleotides, filled circles methylated CpG dinucleotides.
62 S. Santourlidis et al.differentiation (Sikorska et al., 2008). Since USSC show
homogeneous differentiation toward the neural lineage in
vitro (Kögler et al., 2004) we speculated that this
potential could be reflected by appropriate active
epigenetic marks of SOX2 regulatory regions. As exem-
plified in Fig. 3A, we found in various USSC cell lines
that both the distal SRR1 enhancer and the promoter
region are free of DNA methylation except the first CpG
sites of the enhancer, which showed sporadic methyla-
tion. Interestingly, no traces of SOX2 transcripts were
detectable by real-time PCR showing that other mechan-
isms than DNA methylation are responsible for keeping
SOX2 inactive in USSC. On the basis of these findings we
hypothesized, that SOX2 is in an epigenetically active
state and that transcription might thus be readily
initiated on stimulation with an appropriate inducer.Since it is known that OCT4 is a transcriptional activator
of SOX2 expression (Masui et al., 2007) we tested this
hypothesis by transfection of USSC with an OCT4
expression construct. Indeed, 48 h after transfection
high levels of SOX2 transcripts were detectable by
real-time PCR (Fig. 3B).DNA methylation patterns of hTERT combine
characteristics of terminally differentiated and
pluripotent stem cells
The expression of telomerase is a hallmark of embryonic
stem cells and is also found in various adult stem cells
with distinctive self-renewing capacity (Shay and Wright,
2010). The enzyme activity compensates the loss of
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Figure 2 DNA methylation of NANOG promoter in USSC. Schematic outline of the genomic organization of the NANOG –5′ region
including relative position of an Alu element, transcription start site (solid arrow), first exon, and CpG dinucleotides (vertical bars).
Dashed arrows demarcate the region analyzed by bisulfite genomic sequencing. In the lower part, DNA methylation patterns of three
different USSC cell lines are shown. Blank circles indicate unmethylated CpG dinucleotides, filled circles methylated CpG
dinucleotides.
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Figure 3 Methylation status of the SOX2 promoter region and the corresponding SRR1 enhancer in USSC and relative OCT4 and SOX2
transcription after ectopic OCT4 overexpression. Schematic outline of the genomic organization of the SOX2 –5′ region including
relative position of the corresponding SRR1 enhancer, the promoter region, the transcription start side (solid arrow), and all CpG
dinucleotides (vertical bars) analyzed. In the lower part, the methylation pattern of the SRR1 enhancer and of a 344-bp fragment from
the promoter region of the USSC line 4/146 is shown (A). The left diagram shows the OCT4 transcription rate as measured 48 h after
transfection with an OCT4 expression plasmid in USSC cells. The right diagram shows the SOX2 transcription rate measured 48 h after
transfection in the same experimental setting (B).
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64 S. Santourlidis et al.human chromosome ends occurring in every cell division
hence extending the replicative life span. The hTERT –5′
region encompasses a prominent CpG island, which ranges
from –1800 to +2200 from the translational starting point
(Guilleret and Benhattar, 2004). A direct correlation
between hTERT promoter methylation and gene expression
was first reported by Guilleret et al. (2002). Specifically,
a certain part of the promoter and/or the proximal exonic
region must be hypomethylated for hTERT transcription to
take place (Guilleret and Benhattar, 2004; Choi et al.,
2007). USSC cells do not exhibit telomerase activity
despite their extensive proliferative capacity in vitro.
We asked to which extent the DNA methylation pattern of
the hTERT CpG island resembled the situation in ES cells.
Since the bisulfite/sequencing approach is not well suited
for analysis of large genomic regions such as the extended
hTERT –5′ region, we employed the MeDIP technology, in
which CpG islands are precipitated with a methylated
CpG-specific antibody. The precipitate was hybridized to
tiling arrays, covering the complete hTERT promoter
region. As shown in Fig. 4, the hTERT promoter region
was unmethylated in USSC and ES cells, but methylated in
fibroblasts. However, when we compared the methylation
pattern downstream of the transcription start site we
observed that the USSC cells shared similarities in that
respect with both ES cells and fibroblasts (Fig. 4). Thus,
the hTERT methylation pattern in USSC resides in between
the one of a terminal differentiated and a pluripotent
undifferentiated cell.A
B
*  HTERT USSC 
-417
Figure 4 DNA methylation profiles of the CpG island of the hTERT
array technology. Dashed boxes indicate similarities in DNA methyla
indicate similarities between USSC and I3 cells. A dashed arrow depic
–656 relative to the transcription start site is indicated by a solid li
genomic sequencing (B). Here every unmethylated CpG dinucleotide
circle, and not determined CpG positions are depicted by blue circlUncommitted histone signatures of OCT4, SOX2,
and NANOG promoters in USSCN-terminal modifications of histones, representing a second
layer of epigenetic regulation, are influenced by DNA
methylation and vice versa. To address the question if the
DNA methylation status of pluripotency factors would be
accompanied by appropriate histone modifications in the
respective genomic regions, chromatin immunoprecipitation
(ChIP) analyses were performed with antibodies specific for
active (acH3K9, acH4K8, dimeH3K4, and trimeH3K4) as well
as repressive (dimeH3K9 and trimeH3K27) histone modifica-
tions. We analyzed the OCT4, NANOG, and SOX2 promoters
as well as GAPDH as a reference for an active housekeeping
gene. First, to reveal active histone signatures we examined
the human ES cell line I3, which expresses all three
pluripotency factors. As expected, the active gene promo-
ters were acetylated at the acH3K9 and acH4K8 sites and
strongly methylated at the H3K4 site with the dimethylated
modification being more prominent than the trimethylated
one. Moreover, the active histone signature was character-
ized by absence of dimeH3K9 and trimeH3K27 (Fig. 5). In
USSC, the promoters of all three stem cell genes carried the
active mark dimeH3K4 but showed only a moderate degree of
histone acetylation (Fig. 5). Remarkably, we found that the
SOX2 promoter was marked simultaneously by dimeH3K4 and
trimeH3K27 in several USSC lines. This so-called bivalent
histone signature is also found in ESC on developmentally-656
USSC
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fibroblasts
*
gene in USSC, I3 ESC, and fibroblasts determined by NimbleGen
tion profiles between USSC and fibroblasts (A). Dashed ellipses
ts the transcription start site. The 5′ region, ranging from –417 to
ne below the USSC panel and was analyzed in detail by bisulfite
is represented by a blank circle, every methylated one by a black
es.
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Figure 5 Histone modification signatures of pluripotency genes of the ES cell line I3 and of USSCs. Chromatin immunoprecipitations of the ES cell line I3 (upper panel) and the USSC
lines 4/146 (middle panel) and 5/73 (bottom panel) are shown. Results of real–time PCR analyses of the gene promoters of GAPDH, OCT4, NANOG, and SOX2 are shown as indicated
above the panels. Numbers on the x–axis indicate the antibodies used for ChIP: 1, control ab; 2, acH3K9; 3, acH4K8; 4, dimeH3K4; 5, trimeH3K4; 6, dimeH3K9; 7, trimeH3K27. The bars
representing activating modifications are gray whereas black bars depict repressive histone modifications.
65
U
nrestricted
som
atic
stem
cells
from
hum
an
um
bilical
cord
blood
display
66 S. Santourlidis et al.important genes that can be either activated or inhibited
according to the type of exogenous differentiation stimulus
(Bernstein et al., 2006). A similar but less pronounced
bivalent histone signature is seen in the NANOG promoter,
too, as shown for USSC5/73. Interestingly, none of
the promoters exhibited significant levels of dimeH3K9,
which is an established histone mark for constitutively
inactivated genes.Discussion
Cord blood contains hematopoietic, mesenchymal, and
embryonic tissue-like stem cells with considerable prolifer-
ative potential, self-renewal abilities, and various in vitro
differentiation capabilities on stimulation with appropriate
cues (Harris, 2009). It is further hypothesized that cord blood
stem cells might participate in fetal organogenesis (Ratajc-
zak et al., 2008). In fact, somatic stem cells from human
umbilical cord blood display broad differentiation capacity in
vitro (Kögler et al., 2004).
We hypothesized that specific epigenetic determinants on
the level of DNA methylation and histone modifications
might underlie the remarkable differentiation potential of
USSC. Indeed, the present work reveals an unexpected
epigenetic heterogeneity with respect to the DNA methyla-
tion patterns covering the OCT4 –5′ region and the NANOG
promoter. In particular, we observed subpopulations of USSC
cells with partially methylated, weakly methylated, and
sporadically unmethylated OCT4 and NANOG promoters. In
line with that, residual weak OCT4 transcription is detect-
able, presumably arising from the few unmethylated cells.
This epigenetic variability could thus reflect a certain
variability in differentiation capacity among USSC lines as
described recently (Liedtke et al., 2010). In particular, less
methylated USSC cells might reside in a very early
differentiation state and may therefore possess extended
self-renewal and broad differentiation potential. However
after 14 days of osteogenic differentiation a minor increase
of DNA methylation was observed at the OCT4 5′ region,
underlining a direct correlation between DNA methylation
and differentiation state (data not shown). Along the same
lines, the hTERT promoter was found to be unmethylated in
USSC. However, the DNA methylation state of the extended
CpG island overlapping the promoter region showed a more
complex pattern combining characteristics of ES cells with
those of differentiated fibroblasts. Again, acknowledging
that hTERT is not expressed in USSC (Aktas et al., 2010), the
hTERT gene nonetheless is in an epigenetically uncommitted
state that mirrors the uncommitted differentiation state of
the USSC.
Strikingly, the SOX2 promoter and main enhancer were
completely unmethylated, although no trancripts were
detectable. Since in ES cells the same methylation status
correlates with strong expression it can be hypothesized that
either an appropriate activator is missing or a repressor is
present in USSC. In addition, in some USSC lines the SOX2
promoter exhibited a bivalent histone modification signa-
ture, combining the opposing active and repressive histone
marks dimeH3K4 and trimeH3K27. A bivalent histone
signature is typically found in pluripotent stem cells and is
indicative of genes that can be either activated or silenced,depending on the differentiation pathway the cell starts to
pursue (Gan et al., 2007). Notably, on overexpression of
OCT4, a known positive regulator of SOX2, SOX2 transcription
was inducible within 48 h. Thereby at the SOX2 promoter the
ratio between the repressive trimeH3K27 and the activating
dimeH3K4 histone modification turned in favor of the latter
(data not shown). This demonstrates that the “poised” state
of the gene can be resolved toward an active state using an
appropriate stimulus.
It cannot be excluded that the observed bivalent histone
signatures are based on a mixture of USSC with opposing
histone modifications in the same cell preparation. On the
other hand, the clonal origin of the cells and the stable
phenotype across many cell divisions makes this possibility
rather unlikely. It appears to be more likely that our data
reflect true bivalent signatures in the respective USSC lines,
as had been originally described by Lander and colleagues for
ESC (Bernstein et al., 2006). The bivalent epigenetic
signature of SOX2 could be a crucial prerequisite for the
ability of the USSC to enter the neural differentiation
pathway (Kögler et al., 2004). An appropriate activator
acquired in a later differentiation stage could induce SOX2
expression and resolve this uncommitted bivalency. For
proper neurogenesis Sox2 expression is of fundamental
importance (Ferri et al., 2004). Thereby strong gene
expression in neural stem/progenitor cells is driven by the
Sox2 regulatory region 2 (SSR2) which in turn is bound by
class III POU proteins, such as Brn1 and Brn2 and also Sox2
itself (Miyagi et al., 2006).
It is now well established that somatic cells can be
reprogrammed to induced pluripotent stem (iPS) cells by
ectopic overexpression of stem cell factors like OCT4, SOX2,
and NANOG (Zaehres et al., 2010a,b), and it is also known
that epigenetic reprogramming is a rate-limiting step for
successful generation of iPS (Takahashi and Yamanaka, 2006;
Mikkelsen et al., 2008). The uncommitted epigenetic
signatures of OCT4, SOX2, and NANOG as presented here
suggest that USSC might be endowed with a certain degree of
epigenetic plasticity and thus may be a valuable source for
the generation of iPS cells from cord blood. The young age of
cord blood cells, the lack of virus infections, and the fact
that neonatal cells are available from large cord blood banks
make USSC a clinically highly desirable source for iPS
generation. Indeed, it was recently shown that four-factor
reprogramming of USSC to iPS is possible (Zaehres et al.,
2010a,b). It could thus be speculated that the incomplete
DNA methylation and reversible histone modification signa-
tures of key pluripotency genes in these cells would facilitate
the reprogramming process. Moreover, the fact that over-
expression of OCT4 leads to rapid reactivation of SOX2
(Fig. 3) suggests that the reprogramming of USSC might be
possible without overexpression of SOX2, which is currently
under investigation. In general, the knowledge of the factors
defining these properties will provide guidance for novel
direct differentiation protocols ex vivo and hopefully novel
therapeutic applications in regenerative medicine.Conclusions
Our findings show that the early differentiation state and the
multipotent character of unrestricted somatic stem cells
67Unrestricted somatic stem cells from human umbilical cord blood displayfrom umbilical cord blood is reflected by specific epigenetic
signatures of key pluripotency-regulating genes. The stem
cell genes OCT4, NANOG, SOX2, and hTERT are characterized
by an unexpectedly low level of DNA methylation, which
in the case of SOX2 and to a lesser extent NANOG was
associated with a bivalent histone signature that is indicative
for a poised state of transcription. On the basis of these
observations we suggest that USSC preserve a high differen-
tiation potential by keeping stem cell genes in an uncom-
mitted epigenetic state. This uncommitted epigenetic state
might partly explain the unusual differentiation properties of
this somatic stem cell type and furthermore suggests that
USSC are an attractive source for reprogramming to induced
pluripotent stem cells (iPS).Materials and methods
Cell isolation and cultivation
Umbilical cord blood was collected as previously described
with the informed consent of the mothers (Kögler et al.,
1996). USSC cells (SA 8/25 (passage (p)3), SA 5/73 (p4), SA
4/101 (p3), SA 5/60 (p3), SA 4/146 (p4) were isolated from
cord blood and expanded as described by Kögler et al.
(2004). CD34+ HPC were enriched from cord blood using
the Direct CD34 Progenitor Cell Isolation kit (Miltenyi
Biotec). NK cells were purified by flow cytometric cell
sorting to a purity of N98% using the following mAbs: a
combination of anti-CD3 and -CD56. Cell sorting was
performed on a FACStarPlus (BD Biosciences) equipped
with a 2-W argon ion laser (Innova 70; Coherent) operating
at 488 nm and 140 mW. All mAbs including isotype-matched
control mAbs for IgG1 and IgG2a were purchased from
Beckman Coulter unless otherwise noted.Preparation of DNA and analysis of DNA methylation
DNA was extracted using the QIAamp DNA Blood Mini kit
(Qiagen). Genomic sequencing of bisulfite-converted DNA
was performed as described (Santourlidis et al., 2002, 2008).
In short, bisulfite conversion was performed using the
EpiTect kit (Qiagen). PCR primers for specific amplification
of OCT4, NANOG, SOX2, and SRR1 fragments are listed in
Table 1. The TA Cloning kit (Invitrogen) was used for cloning
of the amplification products according to the manufac-
turer`s instructions. Sequence evaluation was performed
with the BigDye Terminator Cycle Sequencing kit (Applied
Biosystems) on a DNA analyzer (3700; Applied Biosystems)
using the M13-as primer. MS-PCR was done with the primers
listed in Table 1. The MS-PCR conditions were initial
denaturation by 95 °C for 14 min, following by 34 cycles of
95 °C for 50 s, TM for 30 s, and 72 °C for 20 s.Ectopic overexpression of OCT4 in USSC
A 1389-bp OCT4 cDNA fragment prepared from I3 ESC
including the ORF was cloned into the EcoRI/XbaI restriction
sites of the expression vector pCL-neo and sequence
confirmed. Transfection was performed using FuGENE HDtransfection reagent from Roche according to the manufac-
turer´s suggestions.
RNA preparation, cDNA synthesis, and real-time PCR
RNA was prepared using the RNeasy Mini Kit (Qiagen)
according to the manufacturer's instructions. First-strand
cDNA synthesis was performed from 1.5 μg RNA by RT using
oligo(dT) (Promega) and Moloney murine leukemia virus
reverse transcriptase (Promega) in a volume of 50 μl at 42 °C
for 1 h. Real-time PCR was carried out with SYBR Green PCR
Mastermix (Applied Biosystems) using 25 ng template cDNA.
All reactions were run in triplicates on an ABI 7700 Detection
System (Applied Biosystems). The sequences for the primers
were carefully examined and checked for their specificity
(Supplementary data, Table 1). Evaluation of TaqMan
Gene Expression Assays (Applied Biosystems) was performed
with the SDS 2.3 software. Relative changes in gene
expression were calculated following the ΔΔCt method with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as in-
ternal standard.
Chromatin immunoprecipitation assay
ChIPs were performed using the ChIP Assay kit according to
the manufacturer's recommendations (Upstate Biotechnolo-
gy). Analyses were done as described previously (Santourlidis
et al., 2008). Abs used for immunoprecipitations were anti-
H4K8ac, anti-H3K4dime, anti-H3K4trime, anti-H3K9ac, and
anti-H3K27trime, all from Upstate Biotechnology, anti-
H3K9dime, which was a gift from Thomas Jenuwein (MPI,
Freiberg), and rabbit anti-human Ig fraction (3 μg/sample) as
isotype control (DakoCytomation). Data calculation leading
to “fold differences” was conducted as described (Mutskov
and Felsenfeld, 2004). In this case, sample values were
normalized by subtraction of the nonspecific signal derived
from the rabbit anti-human Ig fraction instead of calibration
to the “no antibody” control.
DNA methylation analyses by NimbleGen array
technology
One microgram of genomic DNA from each cell type, the
USSC 8/25, the ES cell line I3, and fibroblasts was sonicated
to 300–1000 fragment size by the Vibra Cell 75022 Ultrasonic
Processor. These DNA samples then underwent immunopre-
cipitation of methylated DNA employing the Diagenode´s
MeDIP kit in accordance with the manufacturer´s instruc-
tions. Amplification of input and output samples occurred by
applying the Genome Plex Complete WGA Kit (Sigma Aldrich)
as described in the user´s guide. Hybridization of 1 μg of
each amplified DNA sample was performed on NimbleGen
385 K RefSeq Promoter Arrays HG18 containing all known
RefSeq genes (Roche). The promoter regions on these arrays
are covered by 50-mer probes with approximately 100-bp
spacing. The hybridization procedure was applied as sug-
gested by the manufacturer. The hybridized arrays were
scanned on an Axon 4000B microarray scanner (Molecular
Devices, Sunnyvale CA), and the images were analyzed with
Axon GenePix software version 4.1. Image and data analyses
68 S. Santourlidis et al.were processed with NimbleScan version 2.5 and SignalMap
version 1.9 software.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2010.08.003.Acknowledgments
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